Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
MANE · NYSE · Pharmaceutical Preparations
Veradermics (MANE) · oqro.io/stocks/MANE · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$129.66−5.63 (−4.16%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake, activist · Stake as of Nov 11, 2026 · Filed Nov 13, 2026
Patrick G. Enright disclosed a 9.8% stake in MANE and may seek to influence the companySourceInsider trade · Traded Nov 11, 2026 · Filed Nov 13, 2026
10% owner sold ~$37.6M of MANE shares in the open marketSourceInsider trade · Traded Nov 11, 2026 · Filed Nov 13, 2026
10% owner sold ~$37.6M of MANE shares in the open marketSourceInsider trade · Traded Nov 11, 2026 · Filed Nov 13, 2026
Director sold ~$37.6M of MANE shares in the open marketSourceInsider trade · Traded Nov 11, 2026 · Filed Nov 13, 2026
Director sold ~$37.6M of MANE shares in the open marketSourcePlanned sale · Planned for Nov 11, 2026 · Notice filed Nov 11, 2026
10% owner filed to sell about $37.6M of MANE stockSource5%+ stake · Stake as of Sep 30, 2026 · Filed Oct 13, 2026
JPMORGAN CHASE & CO. now owns 5.6% of MANE as a passive investorSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deep Track Capital, LP disclosed an increased position in MANE for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Maverick Capital Ltd disclosed a new position in MANE for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Frontier Capital Management Co LLC disclosed a new position in MANE for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Paradigm Biocapital Advisors LP no longer reported MANE for Q2 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Montanova Capital, LLC disclosed a new position in MANE for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Viking Global disclosed a new position in MANE for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Paradigm Biocapital Advisors LP disclosed a new position in MANE for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed a new position in MANE for Q1 2026Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Viking Global disclosed a reduced position in MANE for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Siren, L.L.C. disclosed an increased position in MANE for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Siren, L.L.C. disclosed a new position in MANE for Q1 2026Source